Literature DB >> 29132520

Gastroesophageal Reflux Disease.

Rick Kellerman1, Thomas Kintanar2.   

Abstract

Gastroesophageal reflux disease (GERD) is a gastrointestinal motility disorder that results from the reflux of stomach contents into the esophagus or oral cavity resulting in symptoms or complications. The typical symptoms of GERD are heartburn and regurgitation of gastric contents into the oropharynx. GERD affects quality of life and may cause erosive esophagitis, esophageal strictures, and Barrett esophagus, a precursor to esophageal adenocarcinoma. GERD is a clinical diagnosis and is most effectively treated with proton-pump inhibitors (PPIs). Long-term use of PPIs is associated with bone fractures, chronic renal disease, acute renal disease, community-acquired pneumonia, and Clostridium difficile intestinal infection.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrett esophagus; Gastroesophageal reflux disease; Heartburn; Proton pump inhibitors; Regurgitation; Upper endoscopy

Mesh:

Substances:

Year:  2017        PMID: 29132520     DOI: 10.1016/j.pop.2017.07.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  18 in total

1.  Interpretation of machine learning predictions for patient outcomes in electronic health records.

Authors:  William La Cava; Christopher Bauer; Jason H Moore; Sarah A Pendergrass
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

2.  Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison.

Authors:  Su-Yeon Yu; Boram Lee; Treasure M McGuire; Hye-Jae Lee; Samantha A Hollingworth
Journal:  Eur J Clin Pharmacol       Date:  2019-12-10       Impact factor: 2.953

3.  Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements.

Authors:  M Dabir; E Novruzov; K Mattes-György; M Beu; K Dendl; C Antke; S A Koerber; M Röhrich; C Kratochwil; J Debus; U Haberkorn; F L Giesel
Journal:  Mol Imaging Biol       Date:  2022-08-23       Impact factor: 3.484

Review 4.  Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Jiao Xiao; Yunfeng Yang; Yuanrong Zhu; Yan Qin; Yifan Li; Mengjie Fu; Zhengdong Zhai; Lingyun Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-24       Impact factor: 2.629

5.  Hiatal hernia prevalence and natural history on non-contrast CT in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jinhye Kim; Grant T Hiura; Elizabeth C Oelsner; Xiaorui Yin; R Graham Barr; Benjamin M Smith; Martin R Prince
Journal:  BMJ Open Gastroenterol       Date:  2021-03

6.  Prevalence of Gastroesophageal Reflux Disease and Associated Risk Factors in the Eastern Region, Saudi Arabia.

Authors:  Hussain A Al Ghadeer; Zahra E Alabbad; Salwa B AlShaikh; Shaheen U Ahmed; Ali A Bu-Khamseen; Ali T Alhashem; Alaa H Alhamrani; Mohammed R AlGhadeer; Dhiyaa A Alibrahim; Bassil M Alkishi
Journal:  Cureus       Date:  2021-11-15

Review 7.  Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.

Authors:  Mingxing Hou; Haiqing Hu; Chunlu Jin; Xuemei Yu
Journal:  Iran J Public Health       Date:  2020-12       Impact factor: 1.429

Review 8.  Management of gastroesophageal reflux disease in adults: a pharmacist's perspective.

Authors:  Brett MacFarlane
Journal:  Integr Pharm Res Pract       Date:  2018-06-05

Review 9.  Roles of Na+/Ca2+ exchanger 1 in digestive system physiology and pathophysiology.

Authors:  Qiu-Shi Liao; Qian Du; Jun Lou; Jing-Yu Xu; Rui Xie
Journal:  World J Gastroenterol       Date:  2019-01-21       Impact factor: 5.742

10.  Stretta radiofrequency treatment vs Toupet fundoplication for gastroesophageal reflux disease: a comparative study.

Authors:  Lifeng Ma; Tao Li; Guochao Liu; Jianlong Wang; Zhaoqiang Yin; Jiansheng Kang
Journal:  BMC Gastroenterol       Date:  2020-05-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.